StephanieJWShoop1, StephanieMarlow2, DavidBChurch3, KateEnglish4, PaulDMcGreevy5, AnnelieseJStell3, PeterCThomson5, DanGONeill2 and DavidCBrodbelt2
Canine Genetics and Epidemiology20152:1
DOI: 10.1186/2052-6687-2-1
Shoop et al.; licensee BioMed Central.2015
Received: 25June2014
Accepted: 18November2014
Published: 26January2015
Mast cell tumour (MCT) appears to be a frequent tumour type in dogs, though there is little published in relation to its frequency in dogs in the UK. The current study aimed to investigate prevalence and risk factors for MCTs in dogs attending English primary-care veterinary practices.
Electronic patient records from practices participating in the VetCompass animal surveillance project between July 2007 and June 2013 were searched for MCT diagnosis. Various search terms and standard diagnostic terms (VeNom codes) identified records containing MCT diagnoses, which were evaluated against clinical criteria for inclusion to the study. MCT prevalence for the entire dataset and specific breed types were calculated. Descriptive statistics characterised MCT cases and multivariable logistic regression methods evaluated risk factors for association with MCT (P<0.05).
Within a population of 168,636 dogs, 453 had MCT, yielding a prevalence of 0.27% (95% confidence interval (CI) 0.24% - 0.29%). The highest breed type specific prevalences were for the Boxer at 1.95% (95% CI 1.40% - 2.51%), Golden Retriever at 1.39% (0.98% - 1.81%) and Weimaraner at 0.85% (95% CI 0.17% to 1.53%). Age, insurance status, neuter status, weight and breed type were associated with MCT diagnosis. Of dogs of specific breed type, the Boxer, Pug and Staffordshire Bull Terrier showed greater odds of MCT diagnosis compared with crossbred dogs. Conversely, the German Shepherd Dog, Border Collie, West Highland White Terrier, Springer Spaniel and Cocker Spaniel had reduced odds of MCT diagnosis compared with crossbred dogs. No association was found between MCT diagnosis and sex.
This study highlights a clinically significant prevalence of MCT and identifies specific breed types with predisposition to MCT, potentially aiding veterinarian awareness and facilitating diagnosis.
Confidence interval
Electronic patient record
Mast cell tumour
Veterinary nomenclature.
Mast cell tumour (MCT) is the most common skin tumour type in dogs, but little is known about its frequency in the general dog population nor its frequency in particular dog breeds in the UK. This study has investigated the frequency of the disease, and possible risk factors associated with the development of MCT.
This has been conducted by analysing the large number of electronic patient health records contained within the VetCompass animal surveillance project collected between July 2007 and June 2013.
Data were available on a population of 168,636 dogs and within this 453 (0.27%) had MCT. The breeds with the highest breed specific prevalences were Boxer, Golden Retriever and Weimaraner. Conversely, some breeds appeared to be protected.
Age, insurance status, neuter status, weight and breed type were associated with MCT diagnosis. No association was found between MCT diagnosis and gender.
Such information helps to increase awareness of this condition, particularly in certain breeds, to owners and veterinarians.
Mast cell tumours (MCTs) are a frequent tumour type in dogs [1], accounting for 7-21% of cutaneous tumours diagnosed [14]. Dobson and others (2002) reported the incidence of MCT in English dogs as 129 in 100,000 dogs per year [5]; however, this study was limited to insured animals and thus may generalise poorly to the wider population of dogs in England. MCTs occur primarily in the dermis and subcutaneous tissues and can be confirmed in 92-96% of cases through fine needle aspirate (FNA) cytology [6]. Histopathology allows description of the degree of MCT malignancy and clinical grading [6] using two grading systems. Using the Patnaik system, MCTs are categorised into three grades (I, II & III), the third being more clinically important because tumours of this grade are often more aggressive and may metastasise [7]. The more recently proposed Kiupel two tier system categorises MCTs into high or low-grade in order to increase concordance among veterinary pathologists [8].
There are likely to be many factors contributing to the development of MCT which may be genetically influenced [6]. Up to 40% of dogs with subcutaneous and cutaneous MCTs have been found to have mutations in a proto-oncogene, c-kit[6]. Other potential factors include neuter status, sex, age, weight, insurance status and specific breed types. Females [9], and particularly neutered females [10] have been associated with increased risk of MCT in some studies, although other studies failed to identify an association between sex and MCT [11, 12]. While the mean age at presentation of cutaneous MCTs has been reported at between 7.5 and 9years old [9], one study found poorly differentiated (grade III) tumours more common in younger dogs, although the study population consisted of only one breed, the Shar-Pei [13]. Likewise, while one study found no difference in pre-disposition to MCTs between dogs of specific breed types and mixed breed (crossbred) dogs overall [14], certain breed types have previously been associated with this condition. Most commonly, Boxers and Golden Retrievers [10, 15, 16] and other larger breed types have been associated with pre-disposition to MCT whereas smaller breed types are reported to be at lower risk of the condition [10]. Less commonly, breed types including Pugs [10, 17], Weimaraners [15, 16] and the mastiff and terrier phylogenetic clusters [10] have also been associated with having MCTs.
This study aimed to estimate the prevalence and explore risk-factors for the development of MCTs in dogs, using a large sample of animals attending primary-care veterinary practices in England. By identifying factors associated with a higher risk of developing MCTs, it was hoped to improve the index of suspicion for this disease and hence early recognition of this important condition.
The VetCompass system documented 168,636 dogs from a total of 94 veterinary practices within England between 28
June 2007 and 30
June 2013. Of these, 453 dogs met the clinical criteria for inclusion to the study and were classified as dogs presenting with MCT at a participating veterinary practice during the study period. Thus, the MCT prevalence was estimated at 0.27% (95% CI 0.24% to 0.29%) over the study period. Individual breed type MCT prevalences that exceeded this overall estimate included that of the Boxer at 1.95% (95% CI 1.40% to 2.41%), the Golden Retriever at 1.39% (95% CI 0.98% to 1.81%), the Weimaraner at 0.85% (95% CI 0.17% to 1.53%), the Labrador Retriever at 0.72% (95% CI 0.58% to 0.85%), the Staffordshire Bull Terrier at 0.51% (95% CI 0.39% to 0.62%) and the Pug at 0.50% (95% CI 0.13% to 0.88%). Individual breed-type MCT prevalences that fell below the overall estimate included the Springer Spaniel at 0.20% (95% CI 0.06% to 0.35%), the Jack Russell Terrier at 0.16% (95% CI 0.09% to 0.23%), the West Highland White Terrier at 0.07% (95% CI 0.00% to 0.15%), the Border Collie at 0.07% (95% CI 0.00% to 0.14%), the Cocker Spaniel at 0.06% (95% CI 0.00% to 0.12%), the Yorkshire Terrier at 0.04% (95% CI 0.00% to 0.09%) and the German Shepherd Dog at 0.02% (95% CI 0.00% to 0.05) (Table
A). Overall MCT prevalence for dogs of specific breed types was 0.29% (95% CI 0.26 0.32%) and overall crossbred prevalence was 0.18% (95% CI 0.14 0.22) (Table
B).
Breed-type specific prevalence of mast cell tumour (MCT) diagnosis with 95% confidence intervals (CI)
A) Specific breed types
Breed-type
Cases (n)
Total (n)
MCT prevalence (%)
95% CI (%)
Boxer
47
2406
1.95
1.40 - 2.51
Golden Retriever
43
3086
1.39
0.98 - 1.81
Weimaraner
6
705
0.85
0.17 - 1.53
Labrador Retriever
106
14781
0.72
0.58 - 0.85
Staffordshire Bull Terrier
72
14219
0.51
0.39 - 0.62
Pug
7
1391
0.50
0.13 - 0.88
Springer Spaniel
8
3906
0.20
0.06 - 0.35
Jack Russell Terrier
18
11333
0.16
0.09 - 0.23
West Highland White Terrier
3
4254
0.07
0.00 - 0.15
Border Collie
3
4501
0.07
0.00 - 0.14
Cocker Spaniel
4
6353
0.06
0.00 - 0.12
Yorkshire Terrier
2
5512
0.04
0.00 - 0.09
German Shepherd Dog
1
5993
0.02
0.00 - 0.05
See more here:
Prevalence and risk factors for mast cell tumours in dogs ...
- Osmolarity - an overview | ScienceDirect Topics - December 24th, 2021
- Stell Cell Genetics | Stem Cell TV - September 10th, 2019
- Stell Cell Genetics | Stem Cell TV | Page 4 - September 10th, 2019
- Prof. Brian Catchpole - Our People - About - Royal ... - March 14th, 2019
- OMIM Entry - * 104311 - PRESENILIN 1; PSEN1 - March 8th, 2019
- Learn Zone - VetCompass - Royal Veterinary College, RVC - January 27th, 2019
- BRAIN PLASTICITY AND BEHAVIOR - Annual Review of ... - July 17th, 2016
- Salivary Gland Cancer Treatment - National Cancer Institute - July 17th, 2016
- Edward A. Stadtmauer, MD profile | PennMedicine.org - July 17th, 2016
- Dr Emille Reid | Physician | Kuils River | Cape Town - July 17th, 2016
- Publish and perish? - Sveriges Unga Akademi - July 17th, 2016
- Stem Cell Biology - mmrl.edu - July 17th, 2016
- Brendan M. Weiss, MD profile| PennMedicine.org - July 17th, 2016
- The Foundation Fighting Blindness Leadership - July 17th, 2016
- Charcot-Marie-Tooth Disease: A Clinico-genetic Confrontation - July 17th, 2016
- Head and neck squamous cell carcinogenesis: Molecular and ... - July 17th, 2016
- What is a cell? - Genetics Home Reference - July 17th, 2016
- Changes in bacteriophage T7 virion structure at the ... - July 17th, 2016
- The CaV1.4 Calcium Channel Is a Critical Regulator of T ... - July 17th, 2016
- Dr Ad Meyer | Cosmetic and Reconstructive Dentist ... - July 17th, 2016
- Myopia Medications and Genetics - MYOPIA * Prevention - July 17th, 2016
- Chapter 7 - Genetics and Stem Cell Research - Genetics - November 2nd, 2015
- Home | Life Stem Genetics Inc. - November 2nd, 2015
- Ethics of Stem Cell Research (Stanford Encyclopedia of ... - October 21st, 2015
- Myles Brown, MD - DF/HCC - October 16th, 2015
- Dr Izolda Heydenrych | Dermatologist | Cosmetic ... - October 2nd, 2015
- Knoepfler Lab Stem Cell Blog - September 5th, 2015
- Knoepfler Lab Stem Cell Blog | Building innovative ... - September 5th, 2015
- FDA : Stem Cell Cite - September 5th, 2015
- Word Information - an English dictionary about English ... - August 27th, 2015
- Stem Cell Safety - August 17th, 2015
- Therapeutic Cloning - Explore Stem Cells - August 17th, 2015
- Torben Bech-Hansen, PhD Department of Medical Genetics ... - August 7th, 2015
- Cedric Blanpain Lab - People - August 3rd, 2015
- Autologous mesenchymal stem cell therapy for progressive ... - August 3rd, 2015
- Feedback Loops by Helga Kolb Webvision - July 22nd, 2015
- JAX Mice Database - 005557 NOD.Cg-Prkdc Il2rg - July 22nd, 2015
- Reduction of Aeromonas hidrophyla biofilm on stainless ... - July 18th, 2015
- Stem Cells - Times Topics - June 3rd, 2015
- Stem Cells In Use - Learn Genetics - May 31st, 2015
- Genetic Engineering Advantages & Disadvantages Biology ... - May 31st, 2015
- Stell Cell Research Stem Cell Clinic - May 31st, 2015
- Embryonic stem cell - Wikipedia, the free encyclopedia - May 31st, 2015
- Stem Cell Clinic - May 29th, 2015
- Roles of Amacrine Cells by Helga Kolb Webvision - May 25th, 2015
- TOLweb: what is phylogeny? - Tree of Life Web Project - May 23rd, 2015
- Foundation Volume 3, Chapter 55. Molecular Genetic Basis ... - May 23rd, 2015
- Development of the retina and optic pathway - ScienceDirect - May 20th, 2015
- JAX Mice Database - 010636 NOD.Cg-B2m Prkdc - May 20th, 2015
- Arguments Against Embryonic Stem Cell Research - Stem ... - May 19th, 2015
- Department of Zoology, UBC - May 19th, 2015
- The Power of Stem Cells | California's Stem Cell Agency - May 19th, 2015
- Laryngeal Tumors: an overview - Atlas of Genetics and ... - May 19th, 2015
- NIAAA Publications - May 19th, 2015
- Bipolar Cell Pathways in the Vertebrate Retina by Ralph ... - May 19th, 2015
- [I-DNA Deer Placenta] Obama speech - Stem Cells research - - Video - April 8th, 2014
- Stem Cell Study Finds New Treatments For Breast Cancer - Video - February 21st, 2012
- Stem cells - treatable genetic diseases - Video - January 23rd, 2012
- 5 Minutes Bible Study - Stem Cell Research - Video - January 23rd, 2012
- Stem Cells terms - Revision help - Video - January 23rd, 2012
- Latest research worldwide that may benefit people with MS presented by Dr Elizabeth McDonald - Video - January 23rd, 2012
- Genetic Scientists create man-made monster ants - Monkey's from six different animal cells 01-08-12 - Video - January 23rd, 2012
- GVSU Genetics - stem cells - Video - January 5th, 2012
- Coast To Coast AM - 15.11.2011 - 1/4 - Regenerative Medicine/Dulce Base - Video - January 5th, 2012
- A Mississippi Victory as the Battle Over Stem Cell Research Rages on - Video - January 5th, 2012
- Human Cloning - how clones will be made, stem cells and future research funding - Video - January 5th, 2012
- TWO IDENTICALLY CLONED DOGS - GENETIC STEM CELL LABRATORY MADNESS - Video - January 5th, 2012
- Lisa A. Haile, Ph.D., on Patenting Embryonic Stem Cells - Video - January 5th, 2012
- Adult stem cell treatment, quality and testing - Video - January 5th, 2012
- 2011 Summit: Keynote, Evidence-based Development of Stem Cell Therapies, Lawrence Goldstein, PhD - Video - January 5th, 2012
- 8th World Stem Cell Summit Announcement - Video - January 5th, 2012
- RGI on ABC News - World's Largest Embryonic Stem Cell Lines Collection - Video - January 5th, 2012
- Human stem cells in mice - Video - January 2nd, 2012
- 2011 Summit: Stem Cells, Reprogramming and Personalized Medicine, Rudolf Jaenisch, MD - Video - January 1st, 2012
- 2011 World Stem Cell Summit Open Comments - January 1st, 2012
- neo genetics and stem cells - Video - December 31st, 2011
- MY BLOOD-SCIENCE ARISTOTLE REASON GENETICS STEM CELL CLONING NASA ALIEN BABY APOLLO 18 - Video - December 31st, 2011
- Genetic Skin Disease (EB): Spotlight on Stem Cell Research - Welcome - Video - December 31st, 2011
- iPS Stem Cell-Based Treatment of Epidermolysis Bullosa - Video - December 31st, 2011
- Genetic Skin Disease (EB): Spotlight on Stem Cell Research - Patient Advocate - Video - December 31st, 2011